Jun 26, 2024
Regulatory Briefs: What's New in MIDD?
Vivpro Corporation has partnered with experts and industry leaders to discuss critical pharma and biotech topics. Our goal is to share valuable information and allow the audience to engage with questions while they receive real-time feedback.
For our June session, we are joined by Joan Korth-Bradley, PharmD, PhD, FCP, FAAPS, Distinguished Scientist.
Session Overview
This webinar will review how the various applications of mathematical models have been used to enhance drug development by improving decision making, risk mitigation and improving efficiency.
The importance of planning for MIDD will be discussed so that sponsors can best take advantage of opportunities with the FDA's MIDD paired meeting program. Ongoing work of the ICH M15 working group will also be mentioned.
About Joan Korth-Bradley, PharmD, PhD, FCP, FAAPS
Joan Korth-Bradley, PharmD, PhD, FCP, FAAPS has recently joined VivproAI (www.vivpro.ai) as Distinguished Scientist. She brings to her new position over 30 years’ experience in drug development, at Pfizer Inc and Wyeth, focusing on clinical pharmacology. Her experience has included developing new medicines across a broad range of therapeutic areas, including oncology, cardiology, anti-infectives, rheumatology and rare diseases.
